Advanced Cancer
Advanced cancer refers to cancer that has spread beyond its original site to other parts of the body, making it more challenging to treat. Patients may experience a range of symptoms depending on the type and location of the cancer.
Advanced Cancers: FS222 Antibody Treatment
We are evaluating a new antibody medication for individuals with advanced cancers to see if it is safe and effective. This study aims to understand how well FS222 works in treating these conditions.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Technische Universitaet Dresden
Medizinische Fakultät Carl Gustav Carus Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)
Dresden, Germany
Universitaetsklinikum Essen AöR
Klinik für Dermatologie, Venerologie und Allergologie
Essen, Germany
SLK-Kliniken Heilbronn GmbH
Klinikum am Gesundbrunnen
Heilbronn, Germany
Sponsor: Invox Pharma Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.